"","Total","Expected","Hits","Raw p","-log10(p)","Holm adjust","FDR","Impact"
"DNA replication",36,0.50562,4,0.0015471,2.8105,0.53686,0.53686,0
"ErbB signaling pathway",88,1.236,5,0.0078372,2.1058,1,0.89295,0.0063939
"Hedgehog signaling pathway",59,0.82865,4,0.0093295,2.0301,1,0.89295,0.0084325
"Viral life cycle - HIV-1",63,0.88483,4,0.011698,1.9319,1,0.89295,0
"Human papillomavirus infection",362,5.0843,11,0.012867,1.8905,1,0.89295,0.00019654
"Measles",146,2.0506,6,0.016809,1.7745,1,0.97214,0.00025536
"Base excision repair",47,0.66011,3,0.028037,1.5523,1,1,0
"Pantothenate and CoA biosynthesis",51,0.71629,3,0.034589,1.4611,1,1,0.064141
"Mismatch repair",23,0.32303,2,0.040867,1.3886,1,1,0
"Virion - Adenovirus",4,0.05618,1,0.055016,1.2595,1,1,0
"Caffeine metabolism",28,0.39326,2,0.058363,1.2339,1,1,0.018391
"beta-Alanine metabolism",64,0.89888,3,0.060778,1.2163,1,1,0.026631
"mTOR signaling pathway",162,2.2753,5,0.077798,1.109,1,1,0.010184
"Circadian rhythm",36,0.50562,2,0.090542,1.0431,1,1,0
"Neurotrophin signaling pathway",126,1.7697,4,0.10122,0.99475,1,1,0.016862
"Protein processing in endoplasmic reticulum",181,2.5421,5,0.11119,0.95395,1,1,0.0010782
"EGFR tyrosine kinase inhibitor resistance",84,1.1798,3,0.11412,0.94263,1,1,0.0083916
"Polycomb repressive complex",87,1.2219,3,0.12328,0.90909,1,1,0
"Signaling pathways regulating pluripotency of stem cells",140,1.9663,4,0.13417,0.87234,1,1,0.001578
"Taurine and hypotaurine metabolism",46,0.64607,2,0.13613,0.86604,1,1,0.080981
"Folate transport and metabolism",47,0.66011,2,0.14094,0.85098,1,1,0
"African trypanosomiasis",47,0.66011,2,0.14094,0.85098,1,1,0
"Insulin signaling pathway",144,2.0225,4,0.14431,0.8407,1,1,0.024197
"GnRH signaling pathway",96,1.3483,3,0.15226,0.8174,1,1,0.012026
"Longevity regulating pathway",98,1.3764,3,0.15898,0.79866,1,1,0.01747
"AMPK signaling pathway",150,2.1067,4,0.16006,0.79571,1,1,0.0039474
"Non-homologous end-joining",13,0.18258,1,0.16806,0.77454,1,1,0
"Glycerolipid metabolism",101,1.4185,3,0.16922,0.77156,1,1,0.088281
"Neuroactive ligand-receptor interaction",445,6.25,9,0.17351,0.76068,1,1,0
"Nucleotide excision repair",58,0.81461,2,0.19577,0.70826,1,1,0
"AGE-RAGE signaling pathway in diabetic complications",110,1.5449,3,0.20099,0.69682,1,1,0.0011307
"Hepatitis B",165,2.3174,4,0.20196,0.69473,1,1,0.00071863
"Adrenergic signaling in cardiomyocytes",166,2.3315,4,0.20487,0.68853,1,1,0
"Virion - Ebolavirus, Lyssavirus and Morbillivirus",17,0.23876,1,0.21389,0.66981,1,1,0
"Notch signaling pathway",64,0.89888,2,0.22669,0.64456,1,1,0.064706
"Basal cell carcinoma",64,0.89888,2,0.22669,0.64456,1,1,0.083333
"Cytoskeleton in muscle cells",232,3.2584,5,0.22722,0.64356,1,1,0
"Sulfur relay system",19,0.26685,1,0.23586,0.62735,1,1,0
"Vitamin digestion and absorption",68,0.95506,2,0.24751,0.60641,1,1,0
"Axon guidance",182,2.5562,4,0.25285,0.59714,1,1,0.00049217
"Cholinergic synapse",125,1.7556,3,0.2566,0.59074,1,1,0.0010929
"Arginine and proline metabolism",125,1.7556,3,0.2566,0.59074,1,1,0.0041058
"Regulation of lipolysis in adipocytes",71,0.99719,2,0.26317,0.57976,1,1,0
"Acute myeloid leukemia",71,0.99719,2,0.26317,0.57976,1,1,0.001773
"Insulin resistance",130,1.8258,3,0.27562,0.55969,1,1,0.00035403
"Human T-cell leukemia virus 1 infection",252,3.5393,5,0.28015,0.55261,1,1,0.0036374
"HIF-1 signaling pathway",132,1.8539,3,0.28327,0.5478,1,1,0.0014693
"p53 signaling pathway",75,1.0534,2,0.28405,0.5466,1,1,0.00011307
"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis",75,1.0534,2,0.28405,0.5466,1,1,0.033165
"Chemical carcinogenesis - receptor activation",257,3.6096,5,0.29378,0.53198,1,1,0
"Salmonella infection",257,3.6096,5,0.29378,0.53198,1,1,0.001808
"Relaxin signaling pathway",136,1.9101,3,0.29863,0.52487,1,1,0.0037453
"Apoptosis",139,1.9522,3,0.31018,0.50839,1,1,0.0040131
"Focal adhesion",204,2.8652,4,0.322,0.49214,1,1,0.10789
"Arrhythmogenic right ventricular cardiomyopathy",88,1.236,2,0.35129,0.45433,1,1,0
"Breast cancer",150,2.1067,3,0.35258,0.45274,1,1,0.0017857
"ECM-receptor interaction",90,1.264,2,0.36147,0.44192,1,1,0
"RNA polymerase",32,0.44944,1,0.36451,0.43829,1,1,0
"Apoptosis - multiple species",32,0.44944,1,0.36451,0.43829,1,1,0.0016807
"Riboflavin metabolism",32,0.44944,1,0.36451,0.43829,1,1,0.018519
"Th1 and Th2 cell differentiation",91,1.2781,2,0.36654,0.43588,1,1,0.0028169
"Fructose and mannose metabolism",91,1.2781,2,0.36654,0.43588,1,1,0.041441
"Ubiquitin mediated proteolysis",154,2.1629,3,0.36796,0.4342,1,1,0
"Fluid shear stress and atherosclerosis",156,2.191,3,0.37562,0.42525,1,1,0.0010531
"Renin secretion",93,1.3062,2,0.37663,0.42408,1,1,0.0055195
"NOD-like receptor signaling pathway",222,3.118,4,0.37963,0.42064,1,1,0
"Drug metabolism - other enzymes",158,2.2191,3,0.38327,0.41649,1,1,0.016138
"Thyroid hormone synthesis",95,1.3343,2,0.38666,0.41267,1,1,0.00055991
"Small cell lung cancer",97,1.3624,2,0.39662,0.40163,1,1,0
"Gap junction",97,1.3624,2,0.39662,0.40163,1,1,0.0037707
"Viral carcinogenesis",228,3.2022,4,0.3988,0.39925,1,1,0
"Nicotinate and nicotinamide metabolism",98,1.3764,2,0.40157,0.39624,1,1,0.059647
"PI3K-Akt signaling pathway",371,5.2107,6,0.42188,0.37481,1,1,0.010198
"Hepatitis C",169,2.3736,3,0.42491,0.3717,1,1,0
"Endocrine resistance",103,1.4466,2,0.42603,0.37056,1,1,0
"Hypertrophic cardiomyopathy",103,1.4466,2,0.42603,0.37056,1,1,0
"Tight junction",171,2.4017,3,0.43239,0.36413,1,1,0.0028192
"Dilated cardiomyopathy",106,1.4888,2,0.44046,0.35609,1,1,0
"Melanogenesis",106,1.4888,2,0.44046,0.35609,1,1,0.00026427
"Homologous recombination",42,0.58989,1,0.44863,0.34811,1,1,0
"Glycosphingolipid biosynthesis - globo and isoglobo series",42,0.58989,1,0.44863,0.34811,1,1,0.12429
"Choline metabolism in cancer",109,1.5309,2,0.45469,0.34229,1,1,0
"Human immunodeficiency virus 1 infection",246,3.4551,4,0.45558,0.34143,1,1,0.00095388
"Serotonergic synapse",178,2.5,3,0.45827,0.33888,1,1,0.001554
"NF-kappa B signaling pathway",110,1.5449,2,0.45939,0.33782,1,1,0.0009705
"Prostate cancer",111,1.559,2,0.46406,0.33342,1,1,0.0010929
"Glutathione metabolism",111,1.559,2,0.46406,0.33342,1,1,0.011582
"Phenylalanine, tyrosine and tryptophan biosynthesis",44,0.61798,1,0.46408,0.33341,1,1,0
"cAMP signaling pathway",249,3.4972,4,0.4649,0.33264,1,1,0.07774
"Vasopressin-regulated water reabsorption",46,0.64607,1,0.47909,0.31958,1,1,0
"Efferocytosis",184,2.5843,3,0.48005,0.31871,1,1,0.0011688
"Necroptosis",187,2.6264,3,0.4908,0.3091,1,1,0.012422
"TNF signaling pathway",118,1.6573,2,0.49611,0.30442,1,1,0.0021978
"Mucin type O-glycan biosynthesis",49,0.6882,1,0.50084,0.3003,1,1,0.1367
"Growth hormone synthesis, secretion and action",121,1.6994,2,0.50948,0.29288,1,1,0.011161
"Pyrimidine metabolism",122,1.7135,2,0.51388,0.28914,1,1,0.13411
"Various types of N-glycan biosynthesis",51,0.71629,1,0.51483,0.28833,1,1,0
"Leukocyte transendothelial migration",123,1.7275,2,0.51826,0.28546,1,1,0
"Fanconi anemia pathway",52,0.73034,1,0.52169,0.28259,1,1,0.01747
"Ribosome biogenesis in eukaryotes",125,1.7556,2,0.52693,0.27824,1,1,0
"Taste transduction",125,1.7556,2,0.52693,0.27824,1,1,0
"Phosphatidylinositol signaling system",125,1.7556,2,0.52693,0.27824,1,1,0.00017088
"Aldosterone synthesis and secretion",125,1.7556,2,0.52693,0.27824,1,1,0.0038444
"Virion - Hepatitis viruses",53,0.74438,1,0.52844,0.277,1,1,0
"Type II diabetes mellitus",54,0.75843,1,0.5351,0.27157,1,1,0
"Parathyroid hormone synthesis, secretion and action",127,1.7837,2,0.53551,0.27124,1,1,0.0032726
"Endocytosis",276,3.8764,4,0.54581,0.26295,1,1,5.4466e-05
"Cocaine addiction",56,0.78652,1,0.54814,0.26111,1,1,0.0040123
"Prion disease",278,3.9045,4,0.55157,0.2584,1,1,0.0018307
"Thyroid hormone signaling pathway",131,1.8399,2,0.55233,0.2578,1,1,0
"Antifolate resistance",57,0.80056,1,0.55452,0.25608,1,1,0
"Tryptophan metabolism",135,1.8961,2,0.56873,0.2451,1,1,0.018159
"Osteoclast differentiation",139,1.9522,2,0.58469,0.23308,1,1,0.0089527
"Lysosome",140,1.9663,2,0.58861,0.23017,1,1,0
"One carbon pool by folate",63,0.88483,1,0.59099,0.22842,1,1,0.031441
"Yersinia infection",141,1.9803,2,0.59251,0.22731,1,1,0.002904
"Estrogen signaling pathway",142,1.9944,2,0.59637,0.22448,1,1,0
"VEGF signaling pathway",64,0.89888,1,0.59677,0.22419,1,1,0
"Alanine, aspartate and glutamate metabolism",67,0.94101,1,0.61364,0.21209,1,1,0.024795
"MAPK signaling pathway",304,4.2697,4,0.62269,0.20573,1,1,0.0080529
"Alcoholic liver disease",152,2.1348,2,0.63356,0.19821,1,1,0.0058987
"Lipid and atherosclerosis",231,3.2444,3,0.63418,0.19779,1,1,0.0015138
"Pentose phosphate pathway",71,0.99719,1,0.63504,0.1972,1,1,0.020416
"Starch and sucrose metabolism",72,1.0112,1,0.6402,0.19368,1,1,0.0027905
"Gastric cancer",154,2.1629,2,0.64067,0.19337,1,1,0
"Amyotrophic lateral sclerosis",389,5.4635,5,0.64314,0.19169,1,1,0.00021906
"Protein digestion and absorption",155,2.177,2,0.64418,0.19099,1,1,0
"Ether lipid metabolism",73,1.0253,1,0.64529,0.19024,1,1,0.018499
"Butanoate metabolism",74,1.0393,1,0.65031,0.18688,1,1,0.009322
"Cell cycle",157,2.2051,2,0.65113,0.18633,1,1,0.0022146
"Glycerophospholipid metabolism",157,2.2051,2,0.65113,0.18633,1,1,0.094913
"Hippo signaling pathway",158,2.2191,2,0.65456,0.18405,1,1,0
"Carbohydrate digestion and absorption",76,1.0674,1,0.66014,0.18036,1,1,0
"Chronic myeloid leukemia",77,1.0815,1,0.66495,0.17721,1,1,0.0003367
"Fc epsilon RI signaling pathway",77,1.0815,1,0.66495,0.17721,1,1,0.0032653
"Bacterial invasion of epithelial cells",77,1.0815,1,0.66495,0.17721,1,1,0.0033223
"Steroid biosynthesis",77,1.0815,1,0.66495,0.17721,1,1,0.1093
"Non-small cell lung cancer",78,1.0955,1,0.6697,0.17412,1,1,0
"Galactose metabolism",78,1.0955,1,0.6697,0.17412,1,1,0.055815
"Amphetamine addiction",79,1.1096,1,0.67437,0.1711,1,1,0.0023338
"Non-alcoholic fatty liver disease",164,2.3034,2,0.67461,0.17095,1,1,0.001705
"Oxytocin signaling pathway",165,2.3174,2,0.67786,0.16886,1,1,0.0010526
"Adipocytokine signaling pathway",80,1.1236,1,0.67899,0.16814,1,1,0
"Alzheimer disease",408,5.7303,5,0.68448,0.16464,1,1,0.00082547
"Chemical carcinogenesis - DNA adducts",168,2.3596,2,0.68745,0.16276,1,1,0
"RNA degradation",83,1.1657,1,0.69243,0.15962,1,1,0
"Cytosolic DNA-sensing pathway",84,1.1798,1,0.69679,0.1569,1,1,0
"Mineral absorption",84,1.1798,1,0.69679,0.1569,1,1,0
"Cortisol synthesis and secretion",84,1.1798,1,0.69679,0.1569,1,1,0.0014027
"Glycosphingolipid biosynthesis - lacto and neolacto series",84,1.1798,1,0.69679,0.1569,1,1,0.0024627
"Folate biosynthesis",84,1.1798,1,0.69679,0.1569,1,1,0.0029963
"Platinum drug resistance",84,1.1798,1,0.69679,0.1569,1,1,0.0032653
"JAK-STAT signaling pathway",171,2.4017,2,0.6968,0.15689,1,1,0.13438
"Prolactin signaling pathway",85,1.1938,1,0.70109,0.15423,1,1,0.017716
"Cushing syndrome",175,2.4579,2,0.70892,0.1494,1,1,0.00095952
"Antigen processing and presentation",87,1.2219,1,0.7095,0.14905,1,1,0
"Pathways in cancer",579,8.132,7,0.71209,0.14747,1,1,0.00073528
"Human cytomegalovirus infection",260,3.6517,3,0.71222,0.14739,1,1,0
"Glycine, serine and threonine metabolism",88,1.236,1,0.71362,0.14653,1,1,0
"Influenza A",177,2.486,2,0.71482,0.1458,1,1,0
"Colorectal cancer",89,1.25,1,0.71768,0.14407,1,1,0
"Sphingolipid metabolism",90,1.264,1,0.72168,0.14166,1,1,0.049593
"cGMP-PKG signaling pathway",182,2.5562,2,0.72915,0.13718,1,1,0
"Adherens junction",92,1.2921,1,0.72951,0.13697,1,1,0.0001221
"PD-L1 expression and PD-1 checkpoint pathway in cancer",92,1.2921,1,0.72951,0.13697,1,1,0.00094937
"IL-17 signaling pathway",93,1.3062,1,0.73335,0.13469,1,1,0.0017883
"Pathways of neurodegeneration - multiple diseases",513,7.2051,6,0.73384,0.1344,1,1,0.00028058
"PPAR signaling pathway",94,1.3202,1,0.73713,0.13245,1,1,0
"Viral myocarditis",94,1.3202,1,0.73713,0.13245,1,1,0
"Pentose and glucuronate interconversions",95,1.3343,1,0.74086,0.13026,1,1,0.011892
"Insulin secretion",98,1.3764,1,0.75173,0.12394,1,1,0.0015664
"Valine, leucine and isoleucine degradation",99,1.3904,1,0.75526,0.12191,1,1,0.03171
"Fatty acid degradation",102,1.4326,1,0.76553,0.11604,1,1,0.026202
"Motor proteins",198,2.7809,2,0.77099,0.11295,1,1,0
"Tuberculosis",198,2.7809,2,0.77099,0.11295,1,1,0.0021826
"Toll-like receptor signaling pathway",104,1.4607,1,0.77214,0.1123,1,1,0.0068735
"Central carbon metabolism in cancer",106,1.4888,1,0.77857,0.10871,1,1,0
"Circadian entrainment",108,1.5169,1,0.78481,0.10524,1,1,0.023593
"Th17 cell differentiation",109,1.5309,1,0.78787,0.10355,1,1,0.00018315
"Toxoplasmosis",112,1.573,1,0.79678,0.098661,1,1,0
"Parkinson disease",300,4.2135,3,0.79816,0.097907,1,1,0
"Proteoglycans in cancer",211,2.9635,2,0.80076,0.096499,1,1,0.0001005
"MicroRNAs in cancer",303,4.2556,3,0.80366,0.094928,1,1,0
"Herpes simplex virus 1 infection",216,3.0337,2,0.81127,0.090834,1,1,0.00023132
"Alcoholism",217,3.0478,2,0.81331,0.089742,1,1,0.0058586
"Aminoacyl-tRNA biosynthesis",118,1.6573,1,0.81351,0.089638,1,1,0
"Nucleocytoplasmic transport",118,1.6573,1,0.81351,0.089638,1,1,0
"Inositol phosphate metabolism",119,1.6713,1,0.81616,0.088225,1,1,0.091225
"Rap1 signaling pathway",219,3.0758,2,0.81734,0.087597,1,1,0.00022878
"Amoebiasis",121,1.6994,1,0.82135,0.085471,1,1,0
"Huntington disease",314,4.4101,3,0.82275,0.084731,1,1,0.00036841
"Cysteine and methionine metabolism",123,1.7275,1,0.8264,0.082811,1,1,0.081264
"Transcriptional misregulation in cancer",226,3.1742,2,0.83083,0.080486,1,1,0
"Complement and coagulation cascades",125,1.7556,1,0.8313,0.080241,1,1,0
"T cell receptor signaling pathway",126,1.7697,1,0.8337,0.078988,1,1,0
"Kaposi sarcoma-associated herpesvirus infection",228,3.2022,2,0.83452,0.078562,1,1,0
"Oocyte meiosis",127,1.7837,1,0.83607,0.077757,1,1,0.0033613
"Epstein-Barr virus infection",231,3.2444,2,0.83992,0.075763,1,1,0.00059068
"Glucagon signaling pathway",130,1.8258,1,0.84297,0.074187,1,1,0.018954
"Purine metabolism",235,3.3006,2,0.84687,0.072184,1,1,0.066335
"Regulation of actin cytoskeleton",239,3.3567,2,0.85355,0.068773,1,1,0.0046779
"FoxO signaling pathway",138,1.9382,1,0.86,0.065503,1,1,0
"Platelet activation",140,1.9663,1,0.86396,0.063507,1,1,0.0015021
"Sphingolipid signaling pathway",141,1.9803,1,0.8659,0.062534,1,1,0.00090334
"Dopaminergic synapse",148,2.0787,1,0.87872,0.056148,1,1,0
"Thermogenesis",261,3.6657,2,0.88577,0.052677,1,1,0.0055098
"Calcium signaling pathway",265,3.7219,2,0.89088,0.050179,1,1,0
"Phospholipase D signaling pathway",160,2.2472,1,0.89794,0.046753,1,1,0
"Vascular smooth muscle contraction",160,2.2472,1,0.89794,0.046753,1,1,0
"Inflammatory mediator regulation of TRP channels",165,2.3174,1,0.90502,0.04334,1,1,0.0015322
"Amino sugar and nucleotide sugar metabolism",171,2.4017,1,0.91288,0.039585,1,1,0.010552
"Drug metabolism - cytochrome P450",172,2.4157,1,0.91413,0.038992,1,1,8.9847e-05
"Autophagy - animal",173,2.4298,1,0.91536,0.038409,1,1,0.00071556
"Wnt signaling pathway",176,2.4719,1,0.91894,0.036714,1,1,0.0081078
"Cell adhesion molecules",179,2.514,1,0.92237,0.035096,1,1,0
"Cellular senescence",187,2.6264,1,0.93083,0.031131,1,1,0
"Hepatocellular carcinoma",189,2.6545,1,0.93279,0.030214,1,1,0
"ABC transporters",191,2.6826,1,0.93471,0.029325,1,1,0
"Chemokine signaling pathway",198,2.7809,1,0.94098,0.026418,1,1,0
"Steroid hormone biosynthesis",200,2.809,1,0.94266,0.025643,1,1,0.0020304
"Coronavirus disease - COVID-19",344,4.8315,2,0.95713,0.019029,1,1,0
"Neutrophil extracellular trap formation",222,3.118,1,0.95829,0.018503,1,1,0
"Ras signaling pathway",243,3.4129,1,0.96924,0.01357,1,1,0.0028995
"Diabetic cardiomyopathy",256,3.5955,1,0.97453,0.011205,1,1,0
"Ribosome",265,3.7219,1,0.97765,0.0098148,1,1,0
"Spliceosome",265,3.7219,1,0.97765,0.0098148,1,1,0
"Bile secretion",275,3.8624,1,0.98068,0.0084722,1,1,0
"Chemical carcinogenesis - reactive oxygen species",286,4.0169,1,0.98354,0.007207,1,1,4.3066e-05
"Cytokine-cytokine receptor interaction",294,4.1292,1,0.98535,0.0064073,1,1,0
